Maria De Angelis

TL;DR: Changes in Lachnospiraceae abundances according to health and disease are discussed and how nutrients from the host diet can influence their growth and how their metabolites can, in turn, influence host physiology are analyzed.

TL;DR: MD and, to a greater extent, VLPD are effective in the beneficial modulation of gut microbiota, reducing IS and PCS serum levels, and restoring intestinal permeability in CKD patients.

TL;DR: Dietary regimes enriched in polyphenols may efficiently support IBD remission affecting the intestinal dysbiosis, suggesting that polyphenol-enriched diets may create unfavorable conditions for distinct bacterial species.

TL;DR: All the recent scientific discoveries in this field including CD pathogenetic mechanism where gut microbiota might be involved and possible use of probiotics in CD prevention and treatment are illustrated.

TL;DR: Targeting GPBAR-1 might improve liver protection, facilitating beneficial metabolic effects through primary prevention measures and therapeutic aspects, and discuss the complex pathways linked to BA effects, signaling properties of the GPB BAR-1, mechanisms of liver damage, gene-environment interactions, and therapeutic aspect.